Single-chain trail-receptor agonist proteins
AssigneesAbbVie Inc., Apogenix AG
InventorsFritz G. Buchanan, Christian Gieffers, Oliver Hill, Susan E. Lappe, Darren C. Phillips, Meinholf Thiemann
Life of this patent
Estimating the term…
Abstract
Provided herein are specific TRAIL receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a TRAIL-associated disease or disorder. The TRAIL receptor agonist proteins provided herein comprise three soluble TRAIL domains and an Fc fragment. The TRAIL receptor agonist proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.
Claims3
-14. (canceled)
A method of treating a subject having a TRAIL-associated disease or disorder, the method comprising administering to the subject an effective amount of the TRAIL receptor agonist protein of any one of claims 1-7.
-22. (canceled)
Dependencies are inferred from the claim text.